Optivia Biotechnology Email Format
Pharmaceutical ManufacturingCalifornia, United States2-10 Employees
Optivia Biotechnology is a contract research organization based in Santa Clara, California, offering transporter screening services and related solutions that address drug-drug interaction, DMPK, safety, and pharmacology concerns. The company provides transporter-focused assays, informatics products, and customized services aimed at biotechnology, pharmaceutical, and academic customers seeking predictive, best-in-class research support in drug transport mechanisms. Its offerings are positioned to support decision-making across preclinical and early development stages by delivering comprehensive research services and tailored solutions in transporter biology. Optivia’s market footprint places it within the pharmaceutical manufacturing and CRO sector, with a history tied to the development and launch of transporter assay platforms, such as the TransFlex system, and a profile indicating collaboration with industry players in related spaces. The organization is based in Santa Clara, and has historically operated as a small specialized provider within the broader life sciences services landscape. A notable development in its recent history is its acquisition by BioIVT in 2018, signaling integration into a larger CRO platform while continuing to offer transporter-focused research capabilities.